Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

No Association Between Genetic Polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and Nasopharyngeal Carcinoma in Taiwan

Yu-Juen Cheng, Yin-Chu Chien, Allan Hildesheim, Mow-Ming Hsu, I-How Chen, Jerry Chuang, Julia Chang, Yunglin D. Ma, Cheng-Tai Luo, Wan-Lun Hsu, Helen Huei-Hsin Hsu, Hsin Huang, Jing-Fen Chang, Chien-Jen Chen and Czau-Siung Yang
Yu-Juen Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yin-Chu Chien
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan Hildesheim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mow-Ming Hsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I-How Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Chuang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yunglin D. Ma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheng-Tai Luo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wan-Lun Hsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Huei-Hsin Hsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsin Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing-Fen Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chien-Jen Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Czau-Siung Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published February 2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Introduction

NPC2 is rare in most populations around the world but common in southern China and Southeast Asia. Both genetic and environmental factors are purported to account for the development of NPC. Many Phase I and Phase II enzymes get involved in the metabolism of carcinogens. Some of these enzymes are polymorphic in genotypes that show considerable variation in their activities, which, in turn, determine individual susceptibility to cancer risk (1) . No studies to date have examined simultaneously the association between genetic polymorphisms of multiple xenobiotic-metabolizing enzymes and NPC. We have previously reported an association between genetic polymorphism in the CYP2E1 gene and risk of NPC (2) . In this study, we examine the association with NPC of genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, and NAT2.

Materials and Methods

Study Subjects.

The detailed methods of this case-control study have been fully described elsewhere (2) . In brief, incident NPC cases were recruited between July 15, 1991, and December 31, 1994, from two teaching hospitals in Taipei, Taiwan. All cases were newly diagnosed, histologically confirmed with NPC, <75 years old of age, and residing in Taipei city or county for at least 6 months. We identified 378 eligible cases. Controls were individually matched with cases on age (within 5 years), sex, and district/township of residence by using the National Household Registration System. A total of 375 cases (99%) and 327 controls (88%) consented to a detailed interview administered by a trained nurse-interviewer. Blood specimens were obtained from 369 cases and 320 controls. In this study, 337 cases (91% of eligible cases) and 317 controls (99% of eligible controls) were included because DNA from the remaining subjects was exhausted by previous testing for other factors.

Laboratory Analysis.

DNA was extracted from peripheral blood lymphocytes by standard RNase and proteinase K treatment and phenol-chloroform extraction. Genotypes were analyzed using PCR-based methods as described below.

CYP1A1.

The polymorphisms ascribed to MspI in the 3′-flanking region of CYP1A1 were detected by the PCR-RFLP method using the primers described in Kawajiri et al. (3) . The primer sequences were 5′-CAGTGAAGAGTGTAGCCGCT-3′ and 5′-TAGGAGTCTTGTCTCATGCCT-3′. The CYP1A1 polymorphisms were classified as homozygous for m1/m1, heterozygous for m1/m2, or homozygous for m2/m2 alleles.

GSTM1 and GSTT1.

The PCR method for determining GSTM1 and GSTT1 genotypes was the same as that previously reported (4) . The primers of GSTM1 were 5′-CTGCCCTACTTGATTGATGGG-3′ and 5′-CTGGATT- GTAGCGATCATGC-3′. The primers of GSTT1 were 5′-TCACCGGATCATGGCC-AGCA-3′ and 5′-TTCCTTACTGGTCCTCACATCTC-3′.

GSTP1.

Determination of genotype at the GSTP1 locus by the PCR-RFLP method was the same as reported by Harries et al. (5) . The primers were 5′-ACCCCAGGGCTCTATGGGAA-3′ and 5′-TGAGGGCACAAGAAGCCCCT-3′. The GSTP1 polymorphisms were classified as homozygous for GSTP1a (ile105/ile105), heterozygous for GSTP1a/1b (ile105/val105), or homozygous for GSTP1b (val105/val105).

NAT2.

The PCR-RFLP method was the same as reported by Hsieh et al. (6) . The primers were 5′-GGAACAAATTGGACTTGG-3′ and 5′-TCTAGCATGAATCACTCTGC-3′. Individuals with two mutant alleles including NAT2*5, NAT2*6, NAT2*7 or NAT2*14 were classified as slow acetylators; others were classified as rapid acetylators.

Statistical Analysis.

Unconditional logistic regression models were used to estimate the OR and 95% CI to assess the magnitude of the associations between genetic polymorphisms and NPC after controlling for age, sex, and other potential confounders. All statistical significance levels were determined by two-tailed tests. Conditional logistic regression models were not chosen to avoid loss of information from cases and controls without a matched pair. Cases had a slightly higher proportion of Fukkienese ethnicity and lower educational levels than controls. Adjustment for ethnicity and educational level did not alter our findings. This study had at least 80% power to detect a relative risk ≥ 1.5 for each of the genes evaluated.

Results

Frequency distributions of CYP1A1, GSTM1, GSTT1, GSTP1, and NAT2 genotypes and their association with NPC risk are shown in Table 1⇓ . No associations with NPC risk were observed for genetic polymorphisms of GSTM1, GSTT1, GSTP1, and NAT2. We further stratified by anti-EBV antibodies, occupational exposure to wood dust and formaldehyde, and dietary nitrosamine intake; no significant associations of the genotypes examined with NPC risk were noted (data not shown). The frequencies of the CYP1A1 m1 allele among cases and controls were 0.65 and 0.6, respectively. The GSTP1a allele frequencies were 0.69 among cases and 0.85 among controls.

View this table:
  • View inline
  • View popup
Table 1

ORs for developing NPC for genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, and NAT2 after adjustment for age, sex, ethnicity, education level, and exposure to cigarette smoking

Discussion

We previously reported a 2.6-fold (95% CI = 1.2–5.7) increased risk of NPC among individuals homozygous for a variant form of CYP2E1 detected by RsaI digestion (the c2 allele). This motivated us to evaluate genotypes of other Phase I and II metabolizing enzymes. No association with risk of NPC was noted in our study, however, when genotypes of CYP1A1, GSTM1, GSTT1, GSTP1, and NAT2 were evaluated. In one previous study among 83 NPC cases and 114 controls (7) , the GSTM1 null genotype was associated with a marginally significant 1.9-fold (95% CI = 1.0–3.3) increase in NPC risk. Discrepancies with respect to risk associated with the GSTM1 null genotype between this study and that by Nazar-Stewart et al. (7) could be attributable to chance or to true differences in the two populations studied. Most subjects in the study by Nazar-Stewart et al. (7) were Caucasian, and the predominant histological type of NPC was squamous cell carcinoma. In contrast, in our study, all participants were of Chinese descent and the majority of NPC cases were nonkeratinizing or undifferentiated carcinomas.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • ↵1 To whom requests for reprints should be addressed, at Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, 1 Jen-Ai Road Section 1, Taipei 100, Taiwan. E-mail: cjchen{at}ha.mc.ntu.edu.tw

  • ↵2 The abbreviations used are: NPC, nasopharyngeal carcinoma; CYP, cytochrome P450; GST, glutathione S-transferase; RFLP, restriction fragment length polymorphism; OR, odds ratio; CI, confidence interval.

  • Received November 11, 2002.
  • Accepted November 11, 2002.

References

  1. ↵
    d’Errico, A., Malats, N., Vineis, P., and Boffetta, P. Review of studies of selected metabolic polymorphisms and cancer. In: D. P. Vineis, N. Malats, M. Lang, A. d'Errico, N. Caporaso, J. Cuzick, and P. Boffetta (eds.), Metabolic Polymorphisms and Susceptibility to Cancer, pp. 323–393. IARC Scientific Publ. No. 148. Lyon, France: IARC, 1999.
  2. ↵
    Hildesheim A., Anderson L. M., Chen C. J., Cheng Y. J., Brinton L. A., Daly A. K., Reed C. D., Chen I. H., Caporaso N. E., Hsu M. M., Chen J. Y., Idle J. R., Hoover R. N., Yang C. S., Chhabra S. K. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J. Natl. Cancer Inst. (Bethesda), 89: 1207-1212, 1997.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., Watanabe J. Identification of genetic high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett., 263: 131-133, 1990.
    OpenUrlCrossRefPubMed
  4. ↵
    Hung H. C., Chuang J., Chien Y. C., Chern H. D., Chiang C. P., Kuo Y. S., Hildesheim A., Chen C. J. Genetic polymorphisms of CYP2E1. GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol. Biomark. Prev., 6: 901-905, 1997.
    OpenUrlAbstract
  5. ↵
    Harries L. W., Stubbins M. J., Forman D., Howard G. C. W., Wolf C. R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis (Lond.), 18: 641-644, 1997.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Hsieh F. I., Pu Y. S., Chern H. D., Hsu L. I., Chiou H. Y., Chen C. J. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br. J. Cancer, 81: 537-541, 1999.
    OpenUrlCrossRefPubMed
  7. ↵
    Nazar-Stewart V., Vaughan T. L., Burt R. D., Chen C., Berwick M., Swanson G. M. Glutathione S-transferase and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol. Biomark. Prev., 8: 547-551, 1999.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 12 (2)
February 2003
Volume 12, Issue 2
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
No Association Between Genetic Polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and Nasopharyngeal Carcinoma in Taiwan
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
No Association Between Genetic Polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and Nasopharyngeal Carcinoma in Taiwan
Yu-Juen Cheng, Yin-Chu Chien, Allan Hildesheim, Mow-Ming Hsu, I-How Chen, Jerry Chuang, Julia Chang, Yunglin D. Ma, Cheng-Tai Luo, Wan-Lun Hsu, Helen Huei-Hsin Hsu, Hsin Huang, Jing-Fen Chang, Chien-Jen Chen and Czau-Siung Yang
Cancer Epidemiol Biomarkers Prev February 1 2003 (12) (2) 179-180;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
No Association Between Genetic Polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and Nasopharyngeal Carcinoma in Taiwan
Yu-Juen Cheng, Yin-Chu Chien, Allan Hildesheim, Mow-Ming Hsu, I-How Chen, Jerry Chuang, Julia Chang, Yunglin D. Ma, Cheng-Tai Luo, Wan-Lun Hsu, Helen Huei-Hsin Hsu, Hsin Huang, Jing-Fen Chang, Chien-Jen Chen and Czau-Siung Yang
Cancer Epidemiol Biomarkers Prev February 1 2003 (12) (2) 179-180;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Diet Quality and Ovarian Cancer Survival
  • PDE5 inhibitors use and precursors of colorectal cancer
  • Association between serum iron biomarkers and breast cancer
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement